Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Products>This Product

Atlas FT-IR Spectrometer System

Product Description

atlas_ft_ir_system copy.gif

The Atlas FT-IR System is a high performance, automated laboratory reactor with an integrated mid-IR spectrometer. The combination of the Syrris Atlas and Bruker Optics Matrix-MF makes it ideal for real-time analysis of chemical reactions and processes.

The FT-IR Spectrometer is part of Atlas from Syrris, a revolutionary range of modular products, which can form a wide range of lab reactors - designed specifically for research and development chemists. Atlas offers manual or automated control of one or many reactions at a time with volumes from 5 litres to 1ml in jacketed reactors, flasks or vials.

Features & Benefits

Real time, in situ, quantitative analysis: Can be used for analysing product yield, impurities, reaction kinetics, mechanism, end point, etc.

Easy to upgrade: Calorimetry, pH control, gravimetric or volumetric reagent addition, crystallizations, parallel reactions, etc.

Wide temperature and pressure range: -80°C to +180°C and vacuum to 300bar† (†with custom reactors).

Fully automated with integrated analysis: Fully automated reactor control. IR data from the Matrix-MF can be displayed alongside other process data in the Atlas Software.

Wide range of vessel sizes: 50ml, 100ml, 250ml, 500ml, 1L, 2L, 3L* and 5L* (*with remote mount).

Quick change vessel: The oil drain unit, jacketed vessel clamp, auto aligning stirrer and quick oil connectors allow vessels to be changed in under a minute.

Wide wave number range: Analysis is possible from 3,500 to 560cm-1

Easy to use: Twist and click knob, large display and intuitive “drag and drop” software.

Robust: An extremely chemically resistant reactor system and FTIR probe with vibration resistant optics.

Compact: The Atlas footprint of 23cm (9”) square and Matrix-MF footprint of 30cm (12”) square easily fits into fume cupboards.

Product Atlas FT-IR Spectrometer System
Company Syrris Ltd - Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Syrris Ltd - Product Directory
Unit 1, Anglian Business Park Orchard Road, Royston Herts SG8 5TW United Kingdom

Tel: +44 (0) 1763 242555
Fax: +44 (0) 1763 242 992

Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos